(Q46399610)

21 December 2017

title

Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan (English)

1 reference

21 December 2017

author name string

K Abe

1

1 reference

21 December 2017

Y Ikeda

2

1 reference

21 December 2017

T Kurata

3

1 reference

21 December 2017

Y Ohta

4

1 reference

21 December 2017

Y Manabe

5

1 reference

21 December 2017

M Okamoto

6

1 reference

21 December 2017

K Takamatsu

7

1 reference

21 December 2017

T Ohta

8

1 reference

21 December 2017

Y Takao

9

1 reference

21 December 2017

Y Shiro

10

1 reference

21 December 2017

M Shoji

11

1 reference

21 December 2017

T Kamiya

12

1 reference

21 December 2017

H Kobayashi

13

1 reference

21 December 2017

A Koizumi

14

1 reference

21 December 2017

publication date

21 February 2012

1 reference

21 December 2017

European Journal of Neurology

published in

1 reference

21 December 2017

volume

19

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

1070-1078

1 reference

21 December 2017

Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Executive dysfunction in spinocerebellar ataxia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive findings in spinocerebellar ataxia type 2: relationship to genetic and clinical variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive deficits in Machado-Joseph disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Executive and emotional dysfunction in Machado-Joseph disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive impairments in Machado-Joseph disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6 (SCA6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive impairment in spinocerebellar ataxia type 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive change in ALS: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Recent progress in spinocerebellar ataxia type-10 (SCA10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Scale for the assessment and rating of ataxia: development of a new clinical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Reliability and validity of the International Cooperative Ataxia Rating Scale: a study in 156 spinocerebellar ataxia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Validation of the Geriatric Depression Scale--Short Form among inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Apathy following cerebrovascular lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Poststroke apathy and regional cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

An emerging concept. The cerebellar contribution to higher function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive planning deficit in patients with cerebellar atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

The cerebellar cognitive affective syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Evidence for distinct cognitive deficits after focal cerebellar lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognition in hereditary ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive impairment in spinocerebellar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive and social cognitive functioning in spinocerebellar ataxia : a preliminary characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Insight in ALS: awareness of behavioral change in patients with and without FTD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Emotional Lability in MND: Relationship to cognition and psychopathology and impact on caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Treatment of emotional lability in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Frontal type dementia preceding amyotrophic lateral sclerosis: a neuropsychological and SPECT study of five clinical cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Constant blood flow reduction in premotor frontal lobe regions in ALS with dementia - a SPECT study with 3D-SSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

The cerebellum participates in mental activity: tomographic measurements of regional cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Attentional activation of the cerebellum independent of motor involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

Functional magnetic resonance imaging of human brain activity in a verbal fluency task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2012.03669.X

10.1111/J.1468-1331.2012.03669.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

22353375

1 reference

21 December 2017